These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 18663651)

  • 21. Correlation between the treated volume, the GTV and the CTV at the time of brachytherapy and the histopathologic findings in 33 patients with operable cervix carcinoma.
    Muschitz S; Petrow P; Briot E; Petit C; De Crevoisier R; Duvillard P; Morice P; Haie-Meder C
    Radiother Oncol; 2004 Nov; 73(2):187-94. PubMed ID: 15542166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Variation of treatment planning parameters (D90 HR-CTV, D 2cc for OAR) for cervical cancer tandem ring brachytherapy in a multicentre setting: comparison of standard planning and 3D image guided optimisation based on a joint protocol for dose-volume constraints.
    Jürgenliemk-Schulz IM; Lang S; Tanderup K; de Leeuw A; Kirisits C; Lindegaard J; Petric P; Hudej R; Pötter R;
    Radiother Oncol; 2010 Mar; 94(3):339-45. PubMed ID: 19944471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology.
    Pötter R; Haie-Meder C; Van Limbergen E; Barillot I; De Brabandere M; Dimopoulos J; Dumas I; Erickson B; Lang S; Nulens A; Petrow P; Rownd J; Kirisits C;
    Radiother Oncol; 2006 Jan; 78(1):67-77. PubMed ID: 16403584
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
    Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
    Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical outcomes of conventional HDR intracavitary brachytherapy combined with complementary applicator-guided intensity modulated radiotherapy boost in patients with bulky cervical tumour.
    Lu S; Wang S; Kim RY; Zhang J; Wang X; Wang W; Zhu G; Zhou J; Tan Y; Tan M; Li M; Yin G; Li J; Feng M; Lang J
    BJOG; 2023 Jan; 130(2):231-237. PubMed ID: 36330947
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
    Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
    Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uncertainties when using only one MRI-based treatment plan for subsequent high-dose-rate tandem and ring applications in brachytherapy of cervix cancer.
    Kirisits C; Lang S; Dimopoulos J; Oechs K; Georg D; Pötter R
    Radiother Oncol; 2006 Dec; 81(3):269-75. PubMed ID: 17126938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dosimetric comparison of stereotactic MR-guided radiation therapy (SMART) and HDR brachytherapy boost in cervical cancer.
    Dincer N; Ugurluer G; Mustafayev TZ; Serkizyan A; Aydin G; Güngör G; Yapici B; Atalar B; Özyar E
    Brachytherapy; 2024; 23(1):18-24. PubMed ID: 38000958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physics contributions and clinical outcome with 3D-MRI-based pulsed-dose-rate intracavitary brachytherapy in cervical cancer patients.
    Chargari C; Magné N; Dumas I; Messai T; Vicenzi L; Gillion N; Morice P; Haie-Meder C
    Int J Radiat Oncol Biol Phys; 2009 May; 74(1):133-9. PubMed ID: 18774656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential of dose optimisation in MRI-based PDR brachytherapy of cervix carcinoma.
    De Brabandere M; Mousa AG; Nulens A; Swinnen A; Van Limbergen E
    Radiother Oncol; 2008 Aug; 88(2):217-26. PubMed ID: 18037524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dose-volume histogram parameters and local tumor control in magnetic resonance image-guided cervical cancer brachytherapy.
    Dimopoulos JC; Lang S; Kirisits C; Fidarova EF; Berger D; Georg P; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):56-63. PubMed ID: 19289267
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inverse planning simulated annealing for magnetic resonance imaging-based intracavitary high-dose-rate brachytherapy for cervical cancer.
    Kubicky CD; Yeh BM; Lessard E; Joe BN; Speight JL; Pouliot J; Hsu IC
    Brachytherapy; 2008; 7(3):242-7. PubMed ID: 18468959
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parametrial boosting in locally advanced cervical cancer: combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy.
    Mohamed S; Kallehauge J; Fokdal L; Lindegaard JC; Tanderup K
    Brachytherapy; 2015; 14(1):23-8. PubMed ID: 25455382
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined intracavitary and interstitial brachytherapy of cervical cancer using the novel hybrid applicator Venezia: Clinical feasibility and initial results.
    Walter F; Maihöfer C; Schüttrumpf L; Well J; Burges A; Ertl-Wagner B; Mahner S; Belka C; Gallwas J; Corradini S
    Brachytherapy; 2018; 17(5):775-781. PubMed ID: 29941345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy.
    Buyyounouski MK; Horwitz EM; Uzzo RG; Price RA; McNeeley SW; Azizi D; Hanlon AL; Milestone BN; Pollack A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1383-91. PubMed ID: 15275723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DVH parameters and outcome for patients with early-stage cervical cancer treated with preoperative MRI-based low dose rate brachytherapy followed by surgery.
    Haie-Meder C; Chargari C; Rey A; Dumas I; Morice P; Magné N
    Radiother Oncol; 2009 Nov; 93(2):316-21. PubMed ID: 19586673
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adaptive image guided brachytherapy for cervical cancer: a combined MRI-/CT-planning technique with MRI only at first fraction.
    Nesvacil N; Pötter R; Sturdza A; Hegazy N; Federico M; Kirisits C
    Radiother Oncol; 2013 Apr; 107(1):75-81. PubMed ID: 23068712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: clinical feasibility and preliminary results.
    Dimopoulos JC; Kirisits C; Petric P; Georg P; Lang S; Berger D; Pötter R
    Int J Radiat Oncol Biol Phys; 2006 Sep; 66(1):83-90. PubMed ID: 16839702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma.
    Potter R; Kirisits C; Fidarova EF; Dimopoulos JC; Berger D; Tanderup K; Lindegaard JC
    Acta Oncol; 2008; 47(7):1325-36. PubMed ID: 18661430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of alternative biological modelling parameters (α/β and half time of repair T ½ ) on reported EQD2 values in the treatment of advanced cervical cancer.
    De Leeuw AA; Van de Kamer JB; Moerland MA; Philippens ME; Jürgenliemk-Schulz IM
    Radiother Oncol; 2011 Nov; 101(2):337-42. PubMed ID: 21742393
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 42.